Sunshine Biopharma Inc (SBFM)
0.0598
0.00 (0.00%)
USD |
NASDAQ |
Mar 28, 16:00
0.0844
+0.02
(+41.14%)
Pre-Market: 20:00
Sunshine Biopharma Research and Development Expense (Quarterly): 0.238M for Sept. 30, 2023
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
Date | Value |
---|---|
September 30, 2023 | 0.238M |
June 30, 2023 | 0.3686M |
March 31, 2023 | 0.4329M |
December 31, 2022 | 0.0418M |
September 30, 2022 | 0.3625M |
June 30, 2022 | 0.0459M |
March 31, 2022 | 0.3617M |
December 31, 2021 | 0.0912M |
September 30, 2021 | 0.2225M |
June 30, 2021 | 0.1918M |
March 31, 2021 | 0.1668M |
December 31, 2020 | 0.0017M |
September 30, 2020 | 0.00 |
June 30, 2020 | 0.00 |
March 31, 2020 | 0.00 |
December 31, 2019 | 0.00 |
September 30, 2019 | 0.0152M |
June 30, 2019 | |
March 31, 2019 | |
December 31, 2018 | 0.0128M |
September 30, 2018 | 0.00 |
June 30, 2018 | |
March 31, 2018 | |
December 31, 2017 | |
September 30, 2017 |
Date | Value |
---|---|
June 30, 2017 | |
March 31, 2017 | |
December 31, 2016 | 0.00 |
September 30, 2016 | 0.00 |
June 30, 2016 | 0.0328M |
March 31, 2016 | |
December 31, 2015 | 0.00 |
September 30, 2015 | 0.0087M |
June 30, 2015 | 0.00 |
March 31, 2015 | |
December 31, 2014 | 0.004M |
September 30, 2014 | 0.00 |
June 30, 2014 | 0.323M |
March 31, 2014 | 0.096M |
December 31, 2013 | 0.114M |
September 30, 2013 | 0.00 |
June 30, 2013 | 0.00 |
March 31, 2013 | 0.0234M |
December 31, 2012 | 0.00 |
September 30, 2012 | 0.00 |
June 30, 2012 | 0.0018M |
March 31, 2012 | 0.00 |
December 31, 2011 | 0.125M |
September 30, 2011 | 0.00 |
June 30, 2011 | 0.00 |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
Dec 2019
0.4329M
Maximum
Mar 2023
0.1494M
Average
0.0912M
Median
Dec 2021
Research and Development Expense (Quarterly) Benchmarks
Acasti Pharma Inc | 1.443M |
Aurinia Pharmaceuticals Inc | 10.23M |
Edesa Biotech Inc | 0.7045M |
Lexaria Bioscience Corp | 0.5745M |
Xenon Pharmaceuticals Inc | 41.08M |